Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Samsung, Biogen version of AbbVies Humira approved in Europe

      Samsung, Biogen version of AbbVies Humira approved in Europe

      Ruby Khatun Khatun27 Aug 2017 10:30 AM IST
      A biosimilar version of AbbVie Inc’s blockbuster arthritis drug Humira, produced by a joint venture of Biogen Inc and Samsung Biologics, was approved...
      Novartis appoints Bertrand Bodson as Chief Digital Officer

      Novartis appoints Bertrand Bodson as Chief Digital Officer

      Ruby Khatun Khatun27 Aug 2017 9:30 AM IST
      Basel: Novartis announced that Bertrand Bodson, Chief Digital and Marketing Officer for Sainsbury's Argos, has been appointed to the new role of Chief...
      Adamas Pharma secures approval for Parkinsons dyskinesia drug

      Adamas Pharma secures approval for Parkinsons dyskinesia drug

      Ruby Khatun Khatun27 Aug 2017 9:15 AM IST
      The U.S. Food and Drug Administration (FDA) said it had approved Adamas Pharmaceuticals Inc’s treatment for a side effect caused by a commonly...
      DoP invites nominations for 3rd India Pharma and Medical Device Awards

      DoP invites nominations for 3rd India Pharma and Medical Device Awards

      Ruby Khatun Khatun27 Aug 2017 9:04 AM IST
      New Delhi: Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals has decided to confer 3rd India Pharma and...
      NPPA threatens legal action against 40 hospitals for not displaying knee implant prices

      NPPA threatens legal action against 40 hospitals for not displaying knee implant prices

      Ruby Khatun Khatun26 Aug 2017 12:06 PM IST
      New Delhi: National drug pricing regulator NPPA has said 40 hospitals, including Medanta Medicity and Apollo Spectra in the national capital, will...
      FDA clears Novo Nordisk diabetes drug to treat heart diseases

      FDA clears Novo Nordisk diabetes drug to treat heart diseases

      Ruby Khatun Khatun26 Aug 2017 11:00 AM IST
      Novo Nordisk said on Friday the U.S. Food and Drug Administration (FDA) approved its diabetes drug as a treatment to reduce the risk of three major...
      Alembic Pharma sells its Baddi unit to Scott Edil Pharmacia

      Alembic Pharma sells its Baddi unit to Scott Edil Pharmacia

      Ruby Khatun Khatun26 Aug 2017 10:30 AM IST
      Mumbai: Pharma Firm, Alembic Pharmaceuticals (Alembic Pharma) has sold its formulations manufacturing facility at Baddi to Scott Edil Pharmacia...
      Cigna TTK Health to infuse Rs 114 crore for business expansion

      Cigna TTK Health to infuse Rs 114 crore for business expansion

      Ruby Khatun Khatun26 Aug 2017 10:15 AM IST
      Mumbai: Cigna TTK Health Insurance is planning to infuse Rs 114 crore to expand its business, increase distribution network and for upgrading...
      PMDA completes SMS Pharma manufacturing facility inspection

      PMDA completes SMS Pharma manufacturing facility inspection

      Ruby Khatun Khatun26 Aug 2017 10:00 AM IST
      Hyderabad: SMS Pharmaceuticals Limited has announced a successful inspection by Pharmaceuticals and Medical Devices Agency (PMDA), Japan Authorities,...
      New data boosts case for extended use of AstraZeneca heart drug

      New data boosts case for extended use of AstraZeneca heart drug

      Ruby Khatun Khatun26 Aug 2017 9:30 AM IST
      LONDON: AstraZeneca's blood-thinner Brilinta cuts the risk of cardiovascular death by 29 percent in patients with a history of past heart attacks who...
      Medical devices policy must encourage local manufacturing: AiMeD, MTaI 

      Medical devices policy must encourage local manufacturing: AiMeD, MTaI 

      Ruby Khatun Khatun25 Aug 2017 1:36 PM IST
      New Delhi: Medical devices industry on Thursday asked the government to facilitate local development and manufacturing of such equipment under the...
      Lupin initiates recall of tablet Mibelas 24 Fe from US market

      Lupin initiates recall of tablet Mibelas 24 Fe from US market

      Ruby Khatun Khatun25 Aug 2017 11:00 AM IST
      HYDERABAD: Pharma major Lupin, through its USA subsidiary Lupin Pharmaceuticals, Inc has initiated a voluntary recall of tablets Mibelas 24 Fe from...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok